With regards to COVID-19 pathophysiology, blockage of eicosanoid signaling protects mice from severe disease, and apoA-I mimetics attenuate replication of the virus, apoptosis, inflammation, and oxidative stress in vitro [33,34]. The gene discussed is APOA1; the disease is COVID-19.